Abstract
Inherited polymorphisms in the genes controlling the cell cycle or functioning in the DNA repair mechanisms may impair their function and contribute to genetic susceptibility. Abnormalities in the DNA repair have been reported in head and neck cancer. The XRCC1 gene functions in singlestrand break and base excision repair processes. In this study, two polymorphisms of the XRCC1 gene, Arg194Trp and Arg399G1n were investigated in 95 patients with head and neck carcinoma. The polymorphic regions were amplified by PCR followed by digestion with methylation-specific restriction enzymes, and analyzed electrophoretically. Genotype and allele frequencies were calculated, and association with cancer risk or clinical parameters was investigated. No association was observed between the genotypes and head and neck cancer for either polymorphism. Distribution of the alleles did not significantly differ between the patients and the control group. A significant association was only found for the Trp194 allele among the smoking individuals. Our data indicate that the Arg194Trp and Arg399G1n polymorphisms do not confer a significant risk for head and neck carcinogenesis.
Similar content being viewed by others
References
Abdel-Rahman SZ, Soliman AS, Bondy ML, et al: Inheritance of the 194Trp and the 399G1n variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 159: 79–86, 2000
Bohr VA: DNA repair fine structure and its relations to genomic instability. Carcinogenesis 16: 2885–2892, 1995
Butkiewicz D, Rusin M, Enewold L, et al: Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22: 593–597, 2001
Caldecott KW, Aoufouchi S, Johnson P, Shall S: XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADPribose) polymerase, and DNA ligase III is a novel molecular ‘nicksensor’ in vitro. Nucleic Acids Res 24: 4387–4394, 1996
Cappelli E, Taylor R, Cevasco M, et al: Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem 272: 23970–23975, 1997
Crowe DL: Molecular pathology of head and neck cancer. Histol Histopathol 17: 909–914, 2002
David-Beabes GL, London SJ: Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 34: 333–339, 2001
Divine KK, Gilliland FD, Crowell RE, et al: The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res 461: 273–278, 2001
Duell EJ, Millikan RC, Pittman GS, et al: Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10: 217–222, 2001
Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513–1530, 2002
Hu JJ, Mohrenweiser HW, Bell DA, et al: Symposium Overview: Genetic polymorphisms in DNA repair and cancer risk. Toxicol Appl Pharmacol 185: 64–73, 2002
Kubota Y, Nash RA, Klungland A, et al: Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 15: 6662–6670, 1996
Lee SG, Kim B, Choi J, et al: Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett 187: 53–60, 2002
Miller MC, Mohrenweiser HW, Bell DA: Genetic variability in susceptibility and response to toxicants. Toxicol Lett 120: 269–280, 2001
Misra RR, Ratnasinghe D, Tangrea JA, et al: Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191:171–178, 2003
Nelson HH, Kelsey KT, Mott LA, Karagas MR: The XRCC1 Arg399G1n polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 62:152–155, 2002
Olshan AF, Watson MA, Weissler MC, Bell DA: XRCC1 polymorphisms and head and neck cancer. Cancer Lett 178: 181–186, 2002
Park JY, Muscat JE, Ren Q, et al: CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 6: 791–797, 1997
Ratnasinghe D, Yao SX, Tangrea JA, et al: Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10:119–123, 2001
Scully C, Field JK, Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36: 256–263, 2000
Scully C, Field JK, Tanzawa H: Genetic aberrations in oral or head and neck squamous cell carcinoma: 2. Chromosomal aberrations. Oral Oncol 36: 311–327, 2000
Shen MR, Jones IM, Mohrenweiser H: Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604–608, 1998
Shen H, Xu Y, Qian Y, et al: Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. Int J Cancer 88:601–606, 2000
Shu XO, Cai Q, Gao YT, et al: A population based case control study of the Arg399G1n polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12: 1462–1467, 2003
Stern MC, Umbach DM, van Gils CH, et al: DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 10:125–131, 2001
Sturgis EM, Castillo EJ, Li L, et al: Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125–2129, 1999
Sturgis EM, Wei Q: Genetic susceptibility-molecular epidemiology of head and neck cancer. Curr Opin Oncol 14: 310–317, 2002
Taningher M, Malacarne D, Izzotti A, et al: Drug metabolism polymorphisms as modulators of cancer susceptibility. Mutat Res 436:227–261, 1999
Xing DQLJ, Miao X, et al: Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 100: 600–605, 2002
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Demokan, S., Demir, D., Suoglu, Y. et al. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol. Oncol. Res. 11, 22–25 (2005). https://doi.org/10.1007/BF03032401
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03032401